Abstract

When we last reviewed the use of aspirin in vascular disorders we concluded that a preventive effect in coronary thrombosis was uncertain.¹ In 1985 the US Food and Drug Administration accepted, after reviewing the evidence, that aspirin can reduce the likelihood of heart attacks for some patients.² How strong is this evidence?